Did not become law. It stopped in the House of Representatives's Health Committee on September 11, 2018. The 2017–2018 session has ended.
2017–2018 Regular Session
House Bill 2633
An Act amending the act of October 11, 2017 (P.L.347, No.33), known as the Right-to-Try Act, further providing for title of act, for legislative findings and intent, for definitions and for access; providing for the use of investigational stem cell treatments; and further providing for unprofessional conduct and for construction.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the House of Representatives
Sponsor
19 co-sponsors
STEPHEN E. BARRAR, Aaron Bernstine, THOMAS R. CALTAGIRONE, Alexander T. Charlton, MARIA P. DONATUCCI, Michael J. Driscoll, Kristin Phillips-Hill, Carol Hill-Evans, Dawn W. Keefer, JIM MARSHALL, Jeanne McNeill, DAVID R. MILLARD, TINA PICKETT, THOMAS J. QUIGLEY, HARRY A. READSHAW III, STANLEY E. SAYLOR, Judy Ward, David H. Zimmerman, Perry S. Warren
Its course
September 11 to September 11, 2018, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action1 action on 1 day
In the House of RepresentativesSep 11 to Sep 11 · stopped0 days
HealthSep 11 to Sep 11 · stopped0 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.